| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.4269/AJTMH.2006.74.891 |
| P698 | PubMed publication ID | 16687698 |
| P50 | author | Shannon D Putnam | Q54918128 |
| Mark S Riddle | Q114998086 | ||
| David R Tribble | Q114998211 | ||
| P2093 | author name string | John W Sanders | |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diarrhea | Q40878 |
| systematic review | Q1504425 | ||
| military | Q8473 | ||
| P304 | page(s) | 891-900 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
| P1476 | title | Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review | |
| P478 | volume | 74 |
| Q39820594 | A Randomized, Double‐Blind, Placebo‐Controlled Study Evaluating the Efficacy and Safety of Rifaximin for the Prevention of Travelers' Diarrhea in US Military Personnel Deployed to Incirlik Air Base, Incirlik, Turkey |
| Q33577932 | A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni |
| Q37374241 | A case-control study of incident rheumatological conditions following acute gastroenteritis during military deployment. |
| Q39397879 | A prospective study of acute diarrhea in a cohort of United States military personnel on deployment to the Multinational Force and Observers, Sinai, Egypt |
| Q36412063 | A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries |
| Q37896946 | A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression |
| Q37044185 | Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues |
| Q40061261 | Antibiotic resistance in Campylobacter and other diarrheal pathogens isolated from US military personnel deployed to Thailand in 2002-2004: a case-control study |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q90356536 | Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera |
| Q38913633 | CS21 positive multidrug-resistant ETEC clinical isolates from children with diarrhea are associated with self-aggregation, and adherence |
| Q34674326 | Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico |
| Q36159521 | Campylobacter polysaccharide capsules: virulence and vaccines |
| Q36994256 | Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey |
| Q33599807 | Cj0440c Affects Flagella Formation and In Vivo Colonization of Erythromycin-Susceptible and -Resistant Campylobacter jejuni |
| Q93075052 | Clinical endpoints for efficacy studies |
| Q54246807 | Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score. |
| Q57929499 | Comparison of stool collection and storage on Whatman FTA Elute cards versus frozen stool for enteropathogen detection using the TaqMan Array Card PCR assay |
| Q84935450 | Deployment-associated functional gastrointestinal disorders: do we know the etiology? |
| Q44723508 | Development of a travelers' diarrhea vaccine for the military: how much is an ounce of prevention really worth? |
| Q37713347 | Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies |
| Q36539943 | Diagnostic approach to acute diarrheal illness in a military population on training exercises in Thailand, a region of campylobacter hyperendemicity |
| Q33841513 | Enteric disease surveillance under the AFHSC-GEIS: current efforts, landscape analysis and vision forward. |
| Q92063405 | Enteric etiological surveillance in acute diarrhea stool of United States Military Personnel on deployment in Thailand, 2013-2017 |
| Q92106089 | Enterotoxigenic Escherichia coli Infections |
| Q64894189 | Epidemiology and etiology of Traveler's diarrhea in Bangkok, Thailand, a case-control study. |
| Q37638547 | Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations |
| Q93159391 | Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin |
| Q52640720 | Evidence for Somatic Hypersensitivity in Veterans with Gulf War Illness and Gastrointestinal Symptoms. |
| Q36005804 | Facilitated molecular typing of Shigella isolates using ERIC-PCR. |
| Q26782590 | Gastrointestinal Infections in Deployed Forces in the Middle East Theater: An Historical 60 Year Perspective |
| Q37796491 | Gastrointestinal illnesses among French forces deployed to Djibouti: French military health surveillance, 2005-2009 |
| Q33578799 | Global Infectious Disease Surveillance at DoD Overseas Laboratories, 1999-2007 |
| Q35093066 | High number of diarrhoeal co-infections in travellers to Benin, West Africa |
| Q36747100 | Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q36015835 | Incidence, Etiology and Risk Factors for Travelers' Diarrhea during a Hospital Ship-Based Military Humanitarian Mission: Continuing Promise 2011. |
| Q40060447 | Management of Acute Diarrheal Illness During Deployment: A Deployment Health Guideline and Expert Panel Report |
| Q57927103 | Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016 |
| Q28387036 | New Developments in Traveler's Diarrhea |
| Q79612647 | Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle East |
| Q37546154 | Pathogenicity and phenotypic characterization of enterotoxigenic Escherichia coli isolates from a birth cohort of children in rural Egypt |
| Q41050443 | Perceived risk of watery diarrhea and dysentery and intended compliance with chemoprophylaxis among a deployed military population |
| Q40060468 | Preface: Guidelines for the Treatment of Travelers' Diarrhea in Deployed Military Personnel. |
| Q91750459 | Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis |
| Q38557262 | Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations |
| Q34371293 | Quality of systematic reviews of observational nontherapeutic studies |
| Q42202296 | Relative cost-effectiveness of a norovirus vaccine in the deployed military setting compared to a vaccine against Campylobacter sp., ETEC, and Shigella sp. |
| Q43522303 | Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment |
| Q31062841 | Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome |
| Q37477196 | Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. |
| Q38294092 | Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta) |
| Q84554549 | Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers |
| Q84592118 | Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine |
| Q35653427 | Shigella flexneri infection in a newly acquired rhesus macaque (Macaca mulatta) |
| Q47655548 | Strategies to Improve Management of Acute Watery Diarrhea during a Military Deployment: A Cost Effectiveness Analysis |
| Q36204150 | Surveillance of Food- and Smear-Transmitted Pathogens in European Soldiers with Diarrhea on Deployment in the Tropics: Experience from the European Union Training Mission (EUTM) Mali |
| Q85064011 | The Incidence and Gastrointestinal Infectious Risk of Functional Gastrointestinal Disorders in a Healthy US Adult Population |
| Q38035961 | The Shigella human challenge model |
| Q33690915 | The epidemiology of infectious gastroenteritis related reactive arthritis in U.S. military personnel: a case-control study |
| Q36492107 | The three-dimensional structure of CFA/I adhesion pili: traveler's diarrhea bacteria hang on by a spring |
| Q48515252 | Travelers' diarrhea in Thailand: a quantitative analysis using TaqMan® Array Card |
| Q61448554 | Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference? |
| Q45069981 | Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide |
| Q91723105 | Update on Campylobacter vaccine development |
| Q91767150 | Vaccines for enteric diseases |
| Q47722353 | WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report |
Search more.